Senhwa Biosciences Presents Positive Cholangiocarcinoma Data
January 15, 2021 — 22:00 CST
This Data Is Locked!
This area is available only to Subscribers.
TAIPEI and SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
